COVID-19 is an emerging, rapidly evolving situation.

Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus

Coronavirus Guidance for NIH Applicants and Grantees: https://grants.nih.gov/grants/natural_disasters/corona-virus.htm

Dr. Suzan Nadi

Dr. Suzan Nadi

Scientific Review Officer



Biography

Division:
Division of Neuroscience, Development and Aging DNDA
IRG:
Brain Disorders and Clinical Neuroscience BDCN
Study Section:
Clinical Neuroplasticity and Neurotransmitters CNNT

Suzan Nadi received her Ph.D. in biochemistry from Indiana University in Indianapolis, where she worked on the identification of neurotransmitters in cerebellar neurons. In her postdoctoral training at the Roche Institute of Molecular Biology in Nutley, NJ, she focused her research on the neurochemical aspects of the olfactory bulb. Dr. Nadi then joined the NIH Institute of Neurological Disorders and Stroke, where she helped set up its basic research laboratory in epilepsy. Her research there focused on the role of neuropeptide Y and somatostatin in seizures in animal models of seizures and the human brain. Before coming to CSR, Dr. Nadi held a faculty position at George Washington University, teaching neuroanatomy and advancing research on hyperbaric oxygen-induced seizures for the U.S. Navy.